The Cutaneous Connection

Épisodes

• 
  S2 Ep26: New ICD-10 Code Offers Validation for Patients With Topical Steroid Withdrawal 22.07.2026 24min

  In the most recent episode of the Derm Dispatch video series, host Renata Block, DMSCc, MMS, PA-C, a Chicago-based physician assistant, interviewed Kelly Barta, the president and executive director of the International Topical Steroid Awareness Network (ITSAN), to discuss the new ICD-10 code for topical steroid withdrawal and ITSAN's patient registry. The ICD-10 code for TSW went through 3 formal reviews with the CDC and a split board vote before receiving final approval, with support from the American Academy of Dermatology. Barta said the designation gives patients a formal diagnosis within the health system for the first time and allows researchers to begin capturing incidence and prevalence data.
• 
  S2 Ep25: Representation, Education, and Revolutionizing Sunscreen for Skin of Color 08.07.2026 26min

  In this episode, we spoke with Shontay Lundy, founder and CEO of Black Girl Sunscreen, about the inspiration behind building a sunscreen brand designed for people with melanin-rich skin and the broader challenges surrounding sun protection in skin of color. In our discussion, Lundy reflected on gaps in education, representation, product development, and clinical research, while sharing her perspective on how dermatologists, estheticians, brands, and industry leaders can work together to improve sunscreen adoption and skin health outcomes across diverse patient populations.
• 
  S2 Ep24: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment 07.05.2026 18min

  In this episode of The Cutaneous Connection, Dermatology Times revisits a recent video episode of the Derm Dispatch show where host Renata Block, DMSc, MMS, PA-C, sits down with Zachary Rubin, MD — allergist, pediatrician, and New York Times bestselling author of All About Allergies — to explore the intersection of dermatology and allergy. Together, they tackle one of the most persistent myths in practice: that food elimination can treat atopic dermatitis. Dr. Rubin breaks down the difference between IgE-mediated allergic reactions and the complex inflammatory nature of eczema, explains the atopic march, and discusses how understanding the gut-lung-skin axis can empower patients to take charge of their care. The conversation also covers the latest treatment advances — from JAK inhibitors to novel biologics — and touches on indolent systemic mastocytosis and the truth about so-called hypoallergenic dogs. A must-listen for any clinician treating allergic and inflammatory skin disease.For more content, visit https://www.dermatologytimes.com/
• 
  S2 Ep23: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis 01.05.2026 9min

  Join Dermatology Times for a conversation with Liza O'Dowd, MD, vice president of immunodermatology and respiratory disease areas at Johnson & Johnson, recorded at the 2026 AAD Annual Meeting. Dr. O'Dowd discusses one-year efficacy and safety data for icotrokinra (Icotyde), the newly approved once-daily oral peptide IL-23 receptor antagonist for moderate to severe plaque psoriasis in adults and adolescents 12 and older. At 52 weeks, approximately 50% of adult patients achieved total skin clearance, rising to 60% in adolescents enrolled in the LEAD study. Adverse event rates through one year remained within 1.1% of placebo, with no mandatory tuberculosis pre-screening required. Dr. O'Dowd also addresses icotrokinra's anticipated role as a first-line systemic therapy and offers practical reassurance for clinicians considering this novel agent for their patients.For more content from Dermatology Times, visit https://www.dermatologytimes.com/
• 
  S2 Ep22: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment? 09.04.2026 22min

  In this episode, board-certified dermatologist of US Dermatology Partners, Daniel Walker, MD, FAAD, shares emerging insights into the expanding role of GLP-1 receptor agonists beyond their primary use in diabetes and weight loss, highlighting their promising—yet still investigational—impact on inflammatory skin diseases such as psoriasis and HS. 
• 
  S2 Ep21: By the Skin of Your Teeth with The Spizuoco Sisters 23.03.2026 19min

  In this conversation, identical twin practitioners—dermatologist Amy Spizuoco, DO, FAOCD, and dentist Stacy Spizuoco, DDS,—discuss how dentistry and dermatology intersect in shared patients, from oral lesions and skin conditions to cosmetic collaborations that brighten and rejuvenate smiles “by the skin of your teeth.” 
• 
  S2 Ep20: Skin Changes, Hormones, and the Menopause Conversation in Aesthetics 05.03.2026 15min

  In this episode, we sat down with Doris Day, MD, a board-certified dermatologist in New York City, who's 25-year long career focuses on longevity aesthetics. She discussed the most common cutaneous concerns among menopausal women, insights from Galderma’s recent menopause survey, and how dermatologists can thoughtfully incorporate conversations about hormonal health into aesthetic consultations. 
• 
  S2 Ep19: Highlighting Voices of Patients With Indolent Systemic Mastocytosis 21.02.2026 31min

  In the latest installment of Dermatology Times' video series, the Derm Dispatch, host Renata Block, DMSc, MMS, PA-C, sits down with indolent systemic mastocytosis patient advocate Suki Tipp to examine the clinical, emotional, and financial toll of delayed diagnosis—and the critical role dermatology clinicians can play in recognizing this rare disease earlier.Now a vocal advocate, Tipp encourages dermatology clinicians to consider systemic mastocytosis in patients presenting with recurrent urticaria, flushing, unexplained brown macules, and systemic symptoms.
• 
  19: Utilizing the National Eczema Association's EczemaWise App for Clinicians and Patients 10.09.2025 24min

  In a recent Derm Dispatch episode produced by Dermatology Times, Renata Block, DMSc, MMS, PA-C, spoke with Isabelle Thibau, MPH, director of the EczemaWise app from the National Eczema Association (NEA), about the clinical and patient care implications of this digital tool.
• 
  S2 Ep18: ‘A Hairtoric Moment’: Advocating for ICD-10 Codes in Scarring Alopecia 17.12.2024 29min

  Itisha S. Jefferson, a medical student, patient advocate, and one of the co-founders of the Scarring Alopecia Foundation's medical student program, shares the inspiring advocacy journey and team effort behind the approval of ICD-10 codes for scarring alopecias.
• 
  S2 Ep17: Intervening in AD Progression for Pediatric Patients 02.08.2024 3min

  We recently caught up with Peter Lio, MD, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, at the 2024 Society for Pediatric Dermatology Annual Meeting. Lio presented a session on changing the disease course in pediatric atopic dermatitis, alongside Amy Paller, MD. We'll dive into the highlights of their talk, the role of disease progression, and the exciting pipeline ahead.
• 
  S2 Ep16: Food Fight - Drs Treat and Oza Debate Eczema Triggers 14.07.2024 13min

  In today’s episode, Drs Vikash Oza, MD, and James Treat, MD, delve into the topic, “Does Food Trigger Eczema?” Oza, an associate professor of dermatology and pediatrics and the director of pediatric dermatology at NYU in New York City, and Treat, a professor of clinical pediatrics and dermatology at the Perelman School of Medicine and an affiliate of the Children’s Hospital of Philadelphia, participated in 1 of 3 “Great Debates in Peds Derm” at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. The duo shared insights from their debate and pearls for clinicians related to allergy and eczema. 
• 
  S2 Ep15: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD 12.07.2024 11min

  In today’s episode, Albert Yan, MD, FAAP, FAAD, research director at the Children's Hospital of Philadelphia, professor at the Perelman School of Medicine, and executive at Inner Archways LLC, discusses pearls and insights from his lecture presented at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. Yan spoke on artificial intelligence and ChatGPT and the balance of positive yet harmful potential of AI chatbots in medicine. 
• 
  S2 Ep14: Navigating Systemic Therapies in Atopic Dermatitis 01.07.2024 6min

  James Song, MD, FAAD, chief medical officer and director of clinical research at Frontier Dermatology in Seattle, Washington, delves into the complexities and advancements in treating atopic dermatitis (AD). Song highlights the challenges of transitioning patients from topical to systemic therapies, emphasizing the need for timely conversations and patient comfort. He discusses the efficacy and rapid response of oral JAK inhibitors compared to biologics, while addressing safety concerns and the necessity for blood monitoring. Song also explores patient-specific factors in treatment choices, the importance of systemic therapy for moderate to severe cases, and the promise of emerging biologics targeting IL-31 and OX40 pathways. This episode is a comprehensive guide for dermatology clinicians navigating the evolving landscape of AD treatments. 
• 
  S2 Ep13: Enhancing Vitiligo Care With Nanette Silverberg, MD 25.06.2024 11min

  In today’s episode, Nanette Silverberg reviews the key highlights from her vitiligo sessions at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, also known this year as RAVE. Dr. Silverberg is the chief of pediatric dermatology for the Mount Sinai Health System and site director of pediatric and adolescent dermatology at Mount Sinai West and Mount Sinai Beth Israel in New York, as well as the conference chair of the vitiligo portion of RAVE. At the conference, Dr. Silverberg presented “Topical Therapeutics for Vitiligo” and “Excellence in Vitiligo Clinical Practice.” Today, Dr. Silverberg shares the top takeaways from her sessions that clinicians can utilize in their practice. 
• 
  S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story 04.06.2024 18min

  Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
• 
  S2 Ep11: A Reminder of Patient Impact 07.05.2024 5min

  Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.
• 
  S2 Ep10: Make Data-Driven Decisions For Personalized AD Treatment 08.04.2024 10min

  Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, caught up with us at the 2024 American Academy of Dermatology Meeting to decode new atopic dermatitis treatment data and how that translates to personalized options for patients.
• 
  S2 Ep9: Decoding Atopic Dermatitis at AAD 04.03.2024 6min

  Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition. 
• 
  S2 Ep8: ReV Up Your Vitiligo Treatment Strategies 19.12.2023 23min

  Nanette Silverberg, MD, clinical professor of pediatrics and dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, recently led the annual Revolutionizing Vitiligo (ReV) Virtual Conference. Discover what you need to say to overcome insurance coverage hangups with ruxolitinib, the importance of early intervention, and gain an overview of topical guidelines for patients of all ages with vitiligo.